Nanoparticle-delivered CRISPR tools could treat hemophilia, cystic fibrosis and muscular dystrophy – Genetic Literacy Project
Genetic Literacy Project |
Nanoparticle-delivered CRISPR tools could treat hemophilia, cystic fibrosis and muscular dystrophy
Genetic Literacy Project More and more scientists are using the powerful new gene-editing tool known as CRISPR/Cas9, a technology isolated from bacteria, that holds promise for new treatment of such genetic diseases as cystic fibrosis, muscular dystrophy and hemophilia. Genetically modified cows developed using CRISPR/Cas9 technology show improved resistance against TB |
